Background

The Consortium for Advanced Research Training in Africa (CARTA) is an initiative of eight African universities, four African research institutes, and eight non-African partners. CARTA offers an innovative model for doctoral training in sub-Saharan Africa to strengthen the capacity of participating institutions to conduct and lead globally competitive research. CARTA aims to produce a critical mass of high-quality graduates trained to address the complex issues surrounding health and development in Africa, retain them in the region, and provide them with a vibrant intellectual environment, as well as viable and challenging research and growth opportunities.

CARTA is proud to offer three PhD fellowships for staff members of partner institutions who wish to do research in the field of prevention of sexual violence against children (SVAC). Only proposals in this area clearly focused on prevention will be accepted.

CARTA-PreventSVAC PhD Fellowship

As part of its innovations, CARTA offers a collaborative doctoral training program in public and population health. This program has been developed in response to the great challenges faced by Africa’s institutions of higher education in addressing the training and retention of the next generation of academics in the region. Specifically, CARTA seeks to fund candidates who will be future leaders in their institutions. That is, young, capable, and committed individuals who, in time, will ensure that their universities will be the institutions of choice for future generations of academics and university administrators wishing to make a positive impact on public and population health in Africa.

This call for CARTA PhD fellowships is open to staff members of participating institutions who are interested in conducting their PhD research on prevention of sexual violence against children. We welcome applications from any discipline, such as public health, demography, anthropology, communication, medicine, psychology, gender studies, and economics, among others, as long as the research question aims to contribute to increasing the understanding on prevention of sexual violence against children in Africa. CARTA is committed to gender equity in access to the training programs and governance structure and implements a series of interventions to support the progress of women in academia (see CARTA’s gender position). Women are, therefore, particularly encouraged to apply. 

Successful applicants will attend CARTA’s innovative series of Joint Advanced Seminars (JASes) together with the fellows in CARTA Cohort 11. Both the development and delivery of these courses are jointly led by regional and international experts. 

The seminars include didactic sessions, discussions, demonstrations, and practice computer labs. These activities collectively serve to: 

  1. Expose students to key theories and concepts, seminal readings, and research methods of disciplines relevant to public and population health; 
  2. Train students in critical research skills; and 
  3. Build and maintain a network of researchers for scientific collaborations, professional support, and mutually beneficial exchange of scientific resources. 

JASes are offered once annually for four years to each cohort and build skills and conceptual depth from year to year. Each JAS runs for 3 to 4 weeks and some include on-line learning prior to the residential session. Specific topics covered in each JAS include the following (precise dates will be provided later in the fellowship): 

  • JAS1 (March 2025) builds critical thinking, technical skills, and other core research competencies, and introduces students to the essential concepts and seminal articles of the disciplines brought together under CARTA.
  • Inter-JAS (April-October 2025) is an intense fully on-line academic writing course with mandatory assignments that must be submitted within the stipulated timelines.
  • JAS2 (November 2025) focuses on data management and analysis. Fellows learn to use software packages for qualitative and quantitative data management and analyses. Practice sessions use real research data and current software packages for hands-on training 
  • JAS3 (August 2027) focuses on data presentation, the doctoral dissertation, and scientific writing and communication skills to facilitate results dissemination and policy engagement 
  • JAS4 (March 2028) addresses professional development including skills necessary to manage and teach large class sizes, raise and manage research funds, grant writing, and research management. 

As an additional innovation, CARTA will introduce face-to-face and on-line training on researcher self-care and on doing research on contentious issues. This training will start in JAS1 and run through the whole PhD experience and will be offered to all fellows in cohort 11, with particular focus on the three CARTA-PreventSVAC fellows.

With this call, the CARTA program offers three PhD fellowships. They are open to staff members of CARTA African partner institutions who plan to register for their PhD studies at their institution of employment and are eligible for fee waiver. The fellowships, which are tenable at the CARTA African institutions, include the following benefits:

  • The cost of the fellow’s participation in the joint advanced seminars; 
  • A modest monthly stipend and moderate support for research activities; 
  • A laptop loaded with relevant software (1-time license only);
  • Funds to attend one international conference; and 
  • Support to participate in training programs of choice.

Important note: The CARTA fellowships provide financial support for up to 48 months of study, which is accessible according to the guidelines on milestones and graduation (see here). The CARTA-PreventSVAC fellowships will NOT cover tuition fees, medical insurance, or travel support for fellows registered at a partner institution different from their own. Applicants must be staff of partner institutions and will be requested to show evidence of being eligible for fee waiver at the time of submitting the application. These conditions are non-negotiable.

The respective African partner institutions need to commit to continue paying fellows’ salaries (or equivalent) as faculty members and to modify their workloads for the fellows. This is to enable them to fully participate in CARTA-organized activities pertaining to their PhD program and to concentrate on their PhD studies. The partner institutions will also need to commit to waive the fellows tuition fees when they register at the institution where they are employed. Fellows are encouraged to seek supplemental funding to cover additional costs of their doctoral program like additional research costs or further opportunities for training and scholarly exchange.

Eligible African Institutions

  • Obafemi Awolowo University, Nigeria
  • University of Ibadan, Nigeria
  • University of Rwanda, Rwanda
  • Makerere University, Uganda
  • Moi University, Kenya
  • University of Nairobi, Kenya
  • Kamuzu University of Health Sciences, Malawi and its associates (through KUHeS)
  • University of the Witwatersrand, South Africa
  • African Population and Health Research Center, Kenya (only staff members with an agreement for the institution to cover fees and travel, or who can secure funds or a waiver at a CARTA partner institution and travel support – evidence required at the time of application)
  • Agincourt Health and Population Unit, South Africa (only staff members eligible for tuition fee waivers at Wits)
  • Ifakara Health Institute, Tanzania (only staff members with an agreement for the institution to cover fees and travel, or who can secure funds or a waiver at a CARTA partner institution and travel support – evidence required at the time of application)

Eligibility

  • A Master’s degree in a relevant field (MSc, MMed, MPhil).
  • Prior admission into a PhD program is not required for application but awards are contingent on such admission being obtained at one of the participating African universities.
  • Applicants for this program must be full-time teaching or research staff at one of the participating African institutions and should be committed to contributing towards building capacity at their institutions.
  • Applicant’s PhD research proposal must be related to prevention of sexual violence against children in Africa.
  • Fellowships are only open to individuals who have not yet registered for a PhD or are in the very early stages (first year) of the PhD program and are yet to define their research proposal. Fellows seeking support to complete a PhD or secure an additional PhD are not eligible to apply.
  • Applicants must commit to participation in all four annual residential Joint Advanced Seminars (JASes), and to engage in inter-seminar activities designed to keep fellows actively engaged and in continual communication with peers and mentors.
  • Male applicants must be under the age of 40 years and female applicants under the age 45 years.

Application Procedure

  1. Contact the CARTA focal person (access list here) at your institution to discuss your interest and clarify eligibility criteria.
  2. Applicants are expected to submit a full application by September 5, 2024 to THE SECRETARIAT via REDCap (link). The full application includes:
  • A full research proposal (see the link to the form to download and see the required fields and word limit)
  • Updated CV
  • Motivation letter (max 1000 words)
  • Letter of support from their institutional HoD committing to modify the workloads for the fellows, to enable them to fully participate in CARTA-organized activities pertaining to their PhD program and to allow them to dedicate part of their time to their own PhD research. 
  • A scanned copy of their contract with the CARTA partner institution
  • Evidence of eligibility for fee waiver once they are registered at the institution where they are employed. For those at IHI and APHRC, a letter from the institution committing to cover full tuition fees and travel support to the institution of registration
  1. CARTA partner institutions will confirm eligibility of the applicants by September 8, 2024.
  2. Scientific review of the proposals will take place between September 8 – 20, 2024.
  3. Final fellowship decision will be communicated by the CARTA Secretariat by November 1, 2024.

Applications will be accepted ONLY through REDCap (link here). All applicants are encouraged to access the system and start their application before writing anything down. Make sure the system is working and take note of all the required fields. No late or incomplete application will be considered under any circumstance. Deadline for submission is Thursday September 5, 2024, at 5pm EAT. Sharp.

Important Dates

  • September 5, 2024: Deadline for submission of proposals and application materials
  • November 1, 2024: Announcement of final fellowship decisions
  • January 10, 2025: Enrollment for pre-JAS activities (on-line)
  • March 1, 2025: Commencement of fellowship and in-person JAS1 (4 weeks)

CARTA Focal Persons

Institution Focal Person Contact Details
Makerere University, Uganda Prof. Robert Wamala Director, Directorate of Research & Graduate Training
Makerere University, Kampala, UGANDA
Tel: +256 774 515366
Email: wamalar@gmail.com
Dr. John Bosco Isunju Disease Control & Environmental Health Dept
Makerere University, Kampala, UGANDA
Tel: +256-414-530983, Cell: +256-774515366
Fax: +256-414-533809
Email: isunju@musph.ac.ug, ibosco2001@yahoo.com
Obafemi Awolowo University, Nigeria Dr. Melvin Ojo Agunbiade Senior Lecturer, Department of Sociology & Anthropology
Obafemi Awolowo University, Osun State, Ile-Ife, NIGERIA
Tel: +234 805 922 1715
Email: oagunbiade@oauife.edu.ng
Prof. Boladale Mapayi Department of Mental Health
Obafemi Awolowo University, Osun State, Ile-Ife, NIGERIA
Tel: +234 803 393 0096
Email: daledosu@yahoo.com
Moi University, Kenya Prof. Anne Nangulu Deputy Commission Secretary, Quality Audit & Standards Commission for University Education
Moi University, Eldoret, KENYA
Mobile: +254 733 870 502
Email: anangulu@gmail.com
Prof. Christopher Odhiambo Director, School of Postgraduate Studies
Moi University, Eldoret, KENYA
Phone: +254 722 345953
Email: cjodhiambo@hotmail.com
University of Ibadan, Nigeria Prof. Akinyinka Omigbodun College of Medicine
University of Ibadan, NIGERIA
Tel: +234 803 323 0457
Email: omigbodun@yahoo.com, omigbodun@gmail.com
Dr. Funke Fayehun Department of Sociology
University of Ibadan, NIGERIA
Tel: +234 803 323 0457
Email: cl_funke@yahoo.com
University of Rwanda, Rwanda Prof. François Niragire College of Business and Economics
University of Rwanda
Huye-campus, BP 117, Butare, RWANDA
Tel: +250 788 273787
Email:fniragire@ur.ac.rw, fniragiree@gmail.com 
Dr. Mousa Hakizamana College of Medicine and Health Sciences
Po. Box: 3286 Kigali, RWANDA
Email: hakizamoise@gmail.com
Kamuzu University of Health Sciences, Malawi Prof. Adamson S. Muula College of Medicine
Kamuzu University of Health Sciences, Blantyre 3, MALAWI
Tel: +265 884 233 486
Email: amuula@kuhes.ac.mw
Prof. Fanuel Liampao College of Medicine
Kamuzu University of Health Sciences, Blantyre 3, MALAWI
Tel: +265 881 992 652
Email: flampiao@kuhes.ac.mw
University of the Witwatersrand, South Africa Dr. Jude Igumbor Associate Professor, School of Public Health, Faculty of Health Sciences
University of the Witwatersrand, Johannesburg, SOUTH AFRICA
Tel: +27 72 791 59 27
Email: Jude.Igumbor@wits.ac.za, judeigumbor@yahoo.co.uk
Dr. Daphney Conco Senior Lecturer, Health and Society Division
University of the Witwatersrand, Johannesburg, SOUTH AFRICA
Tel: +27 11 717 2502 / 072 072 3305
Email: Daphney.Conco@wits.ac.za
University of Nairobi, Kenya Prof. Alfred Agwanda Otieno Director, Population Studies & Research Institute
University of Nairobi, Nairobi, KENYA
Tel: +254 714 850803
Email: ataotieno@uonbi.ac.ke
Dr. Rose Okoyo Opiyo Chairperson, Department of Public and Global Health
University of Nairobi, Nairobi, KENYA
Tel: +254 722 473122
Email: roseopiyo@uonbi.ac.ke
Share

My journey to becoming a researcher in malaria prevention and control began with the invaluable support of the Consortium for Advanced Research Training in Africa (CARTA), which not only funded my PhD tuition at the University of Nairobi but also provided me with high-level mentors. Their vast expertise and unwavering support were instrumental in shaping my PhD research. In addition, CARTA supported my initial post-PhD research career through a CARTA re-entry grant. This foundation paved the way for my first independent research grant from an external founder, which focuses on maximizing the benefits of Long-Lasting Insecticidal Nets (LLINs) through consistent utilization.

The re-entry grant that I received from CARTA in 2018 was part of the building blocks leading  to the prestigious R01 grant from the National Institutes of Health (NIH). Titled “Real-world Impact of Next-Generation Insecticidal Nets for Malaria Control in Rural Western Kenya,” this grant marks a significant milestone in my academic and research journey. The grant amounting to over USD 600,000 commenced on April 1, 2024 and will continue until March 30, 2029, spanning five years. 

The project will investigate the efficacy of Next Generation LLINs, which combine a pyrethroid with a synergist to combat insecticide resistance, an escalating threat to malaria control. With the World Health Organization now endorsing these nets, their distribution in high-burden counties in Kenya has set the stage for our research.

Our team leverages an existing longitudinal cohort of 500 individuals established in Webuye Sub-County in 2017 to assess the real-world impact of piperonyl-butoxide (PBO) nets. In recruiting the cohorts, we identified villages that were hotspots and coldspots for malaria and randomly sampled households while tracking malaria indicators. Our goal is to understand the human and entomological factors that may affect the nets’ effectiveness, ultimately informing strategies to maximize their impact.

Securing the R01 grant isn’t solely a personal achievement; it signifies an opportunity to contribute significantly to the fight against malaria. By studying the newly distributed PBO LLINs, we want to identify any factors that could reduce the effectiveness of these nets and address them early before they become a bigger problem.

I am forever grateful to CARTA for the opportunities that have propelled me towards my mission of eradicating malaria. CARTA’s support has been invaluable in my transformation into the research leader I aspired to be. I am committed to advancing our understanding of malaria control, aiming to not only save lives, but also to improve health outcomes in Kenya and beyond.

Judith Mangeni, Cohort 3

Senior Lecturer, Department of Epidemiology and Medical Statistics, School of Public Health, Moi University

Share
Olufunke Fayehun, promoted to professor

Olufunke Fayehun, CARTA’s co-focal person at the University of Ibadan, has been promoted to Professor in the Department of Sociology. Before her promotion, Fayehun served as an Associate Professor in the same department.

A distinguished demographer, Fayehun has dedicated her research to vulnerable groups, including children, women, and the elderly. Her work involves collaboration on numerous multi-country and multi-disciplinary studies, contributing significantly to the field.

CARTA extends heartfelt congratulations to Professor Olufunke Fayehun on her well-deserved promotion.

Share

James Kang’ethe, Cohort 10, and a PhD candidate in the Department of Medical Microbiology and Immunology at the University of Nairobi received the prestigious Joep Lange Award for his exceptional presentation at the 2024 International Conference on HIV Treatment, Pathogenesis, and Prevention Research in Resource-Limited Settings (INTEREST).

Held in Cotonou, Benin, from May 14 to 17, INTEREST 2024 brought together scientists focused on HIV research in Africa. James presented his study titled “The Dynamic Interplay of High-Risk Human Papillomavirus in Women Living with HIV: Persistence, Clearance, Incidence, and Synergies with Human T-lymphotropic Virus-1 Infections,” which earned him the distinction of best oral presenter.

The annual INTEREST Conference is a significant platform for scientists engaged in HIV research in Africa, offering opportunities to share key findings, promote collaboration, and discuss local solutions for managing and preventing HIV in resource-limited settings. The conference highlights advancements in HIV diagnosis, treatment, and prevention, fostering a community of African physicians and scientists dedicated to tackling HIV in resource-limited settings.

Share

 

Lilian Njagi, cohort 9, graduate from the University of Nairobi, attended the second EU-Africa PerMed summer school that took place from May 21-23, 2024, at the KCB Leadership Centre in Nairobi, Kenya. During the workshop, she presented on ‘HIV and TB under a Personalised Medicine point of view’, where she shed light on the burden and current management of TB and HIV in Kenya, including TB preventive therapy. This treatment targets high-risk populations with HIV, diabetes, and household contacts. “What is needed is having a mixed workshop where policymakers and big funders hear presentations like yours to convince them that it is not only non-communicable diseases but also communicable diseases that need funding for personalized medicine, and so we might contact you if we have the opportunity to one of our policy-oriented workshops because your presentation was very clear,” said Erika Sela the EU-Africa PerMed coordinator. Lilian is a Clinical Research Scientist at the Kenya Medical Research Institute (KEMRI), Centre for Respiratory Disease Research, with interests in Tuberculosis/HIV co-infection research looking at novel solutions to monitoring the treatment of latent TB to improve outcomes, including assessing the role of immune response and pharmacogenetics.

Share

Imagine a secret green garden filled with plants that can cure your diseases. For thousands of years, people have acknowledged the healing power of plants. And have used them to create various remedies. Even today, many of our medicines are plant-based,turning plants into our small health heroes!

Take the bark of the Cinchona spp  tree, for instance.It yields quinine, a strong medicine to fight malaria. Artemisia annua provides artemisinin, another essential compound. Even today, many of our medicines are plant-based, a testament to the remarkable abilities of these natural healers.

Now, let’s talk about some of the deadliest diseases worldwide according to WHO: lower respiratory infections, HIV, diarrheal diseases, tuberculosis, and malaria. These health threats cause immense suffering and claim millions of lives each year. Sadly, most of these deaths occur in developing countries, to be specific, African countries.

But this is where medicinal plants come in to help us. They offer hope in the fight against these diseases. People turn to plants for relief in places where modern healthcare is scarce. These plants don’t just combat infectious diseases; they also help manage conditions like diabetes.

My work revolves around exploring the hidden powers of medicinal plants. I delve into their antibacterial, antifungal, antimalarial, and antiviral properties. Let’s take HIV, for example—a serious virus, especially prevalent in Africa. Opportunistic infections (OIs) strike harder in people with weakened immune systems due to HIV. These opportunistic infections are a major cause of illness and death among HIV/AIDS patients, especially  in poorer countries.

Guess what? People living with HIV/AIDS often turn to herbal medicines. These plants help manage opportunistic infections and boost their immune systems. Some medicinal plants even directly combat both HIV-1 and HIV-2. But here’s the twist: much of this knowledge remains hidden and not yet explored.

In 2020, we conducted a study in Uganda. Our mission? To document the traditional indigenous knowledge and practices associated with the management of HIV/AIDS infections by herbalists. We searched  the land, capturing the wisdom of herbalists. We documented 236 medicinal plant species from 70 families and 201 genera. Among these, the genus Acacia stood out as the most widely represented, with five species. Some of the plant species were used for treating most of the OI.. 

We found out that despite geographical distances, Ugandan herbalists agreed on which plants to use for different opportunistic infections. Although the herbalists relied on biomedical laboratory diagnoses for confirming the patients’ HIV  status, they were familiar with the signs and symptoms of HIV/AIDS. But a word of caution: improper use of these plants can harm patients. Some practices, like injecting herbs, raise eyebrows. And what about combining herbs with antiretroviral (ARV) drugs? It’s a delicate balance. Mistakes can cause wrong ARV doses or make people stop their treatment.

Speaking of ARVs, they’re vital in managing HIV. However, using them alongside herbal medicines requires care. Incorrect dosages and herb-drug interactions pose risks. 

But here’s the exciting part: by studying these common medicinal plants, we might uncover new treatments—not just for HIV but other diseases too. Plus, cultivating these plants can create jobs and strengthen communities. So, let’s celebrate the power of plants—they’re not just green; they’re life-changing!

 

 Anywar Godwin, Cohort 6

Lecturer, Plant Sciences, Microbiology and Biotechnology, College of Natural Sciences/ School of Biosciences, Makerere University

Share
We'd love your feedback!